Sponsored by:

Nuclear Medicine: Page 333

ACR advises on Tc-99m shortage
By AuntMinnie.com staff writers
The Reston, VA-based American College of Radiology (ACR) says "severe cutbacks" are occurring in nuclear cardiology with the loss of more than 50% of the North American molybdenum-99 (Mo-99) supply, due to the prolonged shutdown of the Chalk River nuclear reactor in Ottawa, Canada.
December 10, 2007
AMIC speeds up launch date for technetium generators
By AuntMinnie.com staff writers
Medical isotope developer Advanced Medical Isotope (AMIC) said that it is accelerating the launch of its compact generator systems and technology in response to the extended shutdown of a Canadian reactor producing the base isotope for technetium-99m.
December 10, 2007
Gamma Medica notches sale to Louisiana health center
By AuntMinnie.com staff writers
Gamma camera developer Gamma Medica-Ideas of Northridge, CA, has sold one of its Flex Triumph multimodality preclinical molecular imaging systems to Louisiana State University Health Sciences Center in Shreveport.
December 6, 2007
Warning issued on radioisotope supply
By Wayne Forrest
Radioisotope maker Atomic Energy of Canada Ltd.'s (AECL) National Research Universal reactor in Chalk River, Ontario, will be offline for at least one more month, leaving hundreds of thousands of medical tests worldwide in jeopardy.
December 5, 2007
Bristol-Myers Squibb to divest imaging unit, including Cardiolite radiopharmaceutical
By Brian Casey
Pharmaceutical giant Bristol-Myers Squibb is planning to sell off its medical imaging unit as part of a restructuring of the New York City-based company. The firm's medical imaging division markets the Cardiolite technetium-based radiopharmaceutical, as well as other radiopharmaceuticals and ultrasound contrast media.
December 4, 2007
Neoprobe, Cardinal Health ink distribution deal
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has signed a distribution agreeement with healthcare products firm Cardinal Health, also of Dublin, for the marketing and distribution of its Lymphoseek radiopharmaceutical through Cardinal's network of more than 150 nuclear pharmacies.
November 27, 2007
IBA, PETLinQ acquire SourceMedical's radiology division
By AuntMinnie.com staff writers
IBA Molecular, North America and PETLinQ have acquired the radiology division of SourceMedical. The acquisition will expand the companys' product line to include the SourceRad RIS and billing system.
November 25, 2007
New contrast agent could replace some nuclear stress testing with echo
By Eric Barnes
Researchers in the U.K. believe that an investigative echocardiography contrast agent could soon be used to replace nuclear cardiography stress exams for the initial detection of coronary artery disease. Their preliminary results of two trials suggest that perfusion stress echocardiography is as accurate as nuclear stress testing for detecting coronary artery disease.
November 21, 2007
Lack of IV contrast causes discrepancy in CT with PET scans
By Wayne Forrest
A study to determine the diagnostic limitations of low-dose, unenhanced CT scans performed for anatomic reference and attenuation correction during PET/CT has found that most discrepancies were due to the lack of intravenous contrast, which obscured liver metastases and lymph node recognition.
November 21, 2007
2007 11 21 16 05 05 706
Siemens makes FLT available to NCI research sites
By AuntMinnie.com staff writers
Siemens Medical Solutions said that the U.S. National Cancer Institute (NCI) has filed a cross-reference letter related to the company's investigational F-18 FLT imaging biomarker.
November 20, 2007
Dilon hires new sales VP
Scintimammography developer Dilon Technologies of Newport News, VA, has hired a new vice president in charge of sales and business development.
November 18, 2007
FDG-PET works for nose cancer staging, study finds
By Kate Madden Yee
FDG-PET can replace conventional workup in primary M staging of nonkeratinizing nasopharyngeal carcinoma (NPC), according to researchers at Chang Gung University College of Medicine in Taipei, Taiwan. The team compared the diagnostic efficacies of FDG-PET and CWU, as well as a combination of the two, in detecting distant metastasis.
November 14, 2007
2007 11 14 15 34 50 706
Previous Page
Page 333 of 440
Next Page